Mfg Part Number
bAb0615-BS

Vector Labs bAb0615-BS Anti-PD-L1 [10F.9G2], Mouse IgG2a mCD3e KIH bispecific, Fc Silent™, kappa (1 mg)

Quick Overview
This antibody was raised by immunising Lewis rats with murine PD-L1 cDNA and murine PD-L1 CHO transfectants.
$4,197.70
Order will ship within 1-3 business days
Add to Wish List
Product Class:Purified
Clone ID:10F.9G2
Heavy Chain Modification:Fc Silent™
Synonyms:CD274; PDL1; PD L1; Programmed cell death 1 ligand 1; PDCD1 ligand 1; Programmed death ligand 1; B7 homolog 1; B7-H1; 10F9G2; 10F 9G2
Amount:1 mg
Application Codes Clone:ELISA; FC; IHC; blocking
Shipping Temperature:Wet Ice
Buffer Composition:PBS only.
Original Format:IgG2b
Storage Temperature:Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C.
Chimeric Use Statement:This is a bispecific, knob-into-hole heterodimerized antibody, with one arm directed against mouse PD-L1 (Fab) and one arm directed against mouse CD3e (scFv).
Specificity Statement:This antibody is specific for murine PD-L1.
Application Notes:The specificity of this antibody has been confirmed in ELISA analysis (Eppihimer et al, 2002). This antibody reacts specifically with mPD-L1-transfected cells in flow cytometry, and has been used to assess microvascular endothelial cells PD-L1 expression (Eppihimer et al, 2002). When administered to mice, a radiolabelled version of this antibody has been used to quantify PD-L1 expression in vivo, by measuring antibody accumulation in different tissues (Eppihimer et al, 2002). This antibody has also been used in immunohistochemical analysis of PD-L1 expression in frozen tissue sections of murine brain (Eppihimer et al, 2002) and murine hearts (Rodig et al, 2003). This antibody has been shown to block the binding of PD-L1 to both PD-1 and B7-1 (Paterson et al, 2011). This antibody precipitates diabetes in NOD mice and in adoptive transfer models of CD4+ and CD8+ T cell-driven diabetes, and accelerates diabetes in recipients of T cells from diabetic and prediabetic mice (Paterson et al, 2011).
More Information
Brand Vector Labs
UNSPSC 12161500